Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 10:2018:7156435.
doi: 10.1155/2018/7156435. eCollection 2018.

Aging-Induced Biological Changes and Cardiovascular Diseases

Affiliations
Review

Aging-Induced Biological Changes and Cardiovascular Diseases

James Oluwagbamigbe Fajemiroye et al. Biomed Res Int. .

Abstract

Aging is characterized by functional decline in homeostatic regulation and vital cellular events. This process can be linked with the development of cardiovascular diseases (CVDs). In this review, we discussed aging-induced biological alterations that are associated with CVDs through the following aspects: (i) structural, biochemical, and functional modifications; (ii) autonomic nervous system (ANS) dysregulation; (iii) epigenetic alterations; and (iv) atherosclerosis and stroke development. Aging-mediated structural and biochemical modifications coupled with gradual loss of ANS regulation, vascular stiffening, and deposition of collagen and calcium often disrupt cardiovascular system homeostasis. The structural and biochemical adjustments have been consistently implicated in the progressive increase in mechanical burden and functional breakdown of the heart and vessels. In addition, cardiomyocyte loss in this process often reduces adaptive capacity and cardiovascular function. The accumulation of epigenetic changes also plays important roles in the development of CVDs. In summary, the understanding of the aging-mediated changes remains promising towards effective diagnosis, discovery of new drug targets, and development of new therapies for the treatment of CVDs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Aging processes, prevalence of aging-related diseases, and some selected cardiovascular diseases.
Figure 2
Figure 2
Summary of the complex alterations in aging-induced cardiovascular diseases.

References

    1. Townsend N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: Epidemiological update 2016. European Heart Journal. 2016;37(42):3232–3245. doi: 10.1093/eurheartj/ehw334. - DOI - PubMed
    1. Hill K. M., Bara A.-C., Davidson S., House A. O. Preventive cardiovascular care for older people: Fundamental for healthy ageing? Age and Ageing. 2013;42(6):675–676. doi: 10.1093/ageing/aft147.aft147 - DOI - PubMed
    1. Cruz-Jentoft A. J., Boirie Y., Cederholm T. Issues concerning sarcopenia in ageing adults. Age and Ageing. 2015;44(2):343–344. doi: 10.1093/ageing/afu208. - DOI - PubMed
    1. Kochanek K. D., Murphy S. L., Xu J., Tejada-Vera B. Deaths: Final Data for 2014. National Vital Statistics Reports. 2016;65(4):1–122. - PubMed
    1. DiLoreto R., Murphy C. T. The cell biology of aging. Molecular Biology of the Cell. 2015;26(25):4524–4531. doi: 10.1091/mbc.e14-06-1084. - DOI - PMC - PubMed

LinkOut - more resources